Search Login Register

Breast Neoplasms (Breast Cancer) Summary

65247 relevant articles (3868 outcomes, 14214 trials/studies) found for this Disease

Description: Tumors or cancer of the human BREAST.

Also Known As: Breast Cancer; Cancer, Breast; Breast Tumors; Neoplasms, Breast; Cancer of Breast Show All >>

Key Drugs and Agents for Breast Neoplasms

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Tamoxifen : 566 outcomes 1416 studies in 5122 results : FDA 12 Generic
  2. Estrogens (Estrogen) : 230 outcomes 1110 studies in 8313 results : FDA 1
  3. Paclitaxel (Taxol) : 227 outcomes 516 studies in 1401 results : FDA 12 Generic
  4. trastuzumab (Herceptin) : 223 outcomes 345 studies in 1436 results : FDA 1
  5. Hormones : 198 outcomes 713 studies in 5032 results : IBA
  6. docetaxel (Taxotere) : 192 outcomes 480 studies in 1014 results : FDA 2
  7. Doxorubicin (Adriamycin) : 191 outcomes 617 studies in 2036 results : FDA 12 Generic
  8. Cyclophosphamide (Cytoxan) : 173 outcomes 603 studies in 1731 results : FDA 11 Generic
  9. Fluorouracil (Carac) : 131 outcomes 470 studies in 1459 results : FDA 32 Generic
  10. Epirubicin (Ellence) : 110 outcomes 350 studies in 770 results : FDA 10 Generic
Show All >>

Diseases Related to Breast Neoplasms

  1. Neoplasms (Cancer)
  2. Neoplasm Metastasis (Metastasis)
  3. Breast Neoplasms (Breast Cancer)
  4. Carcinoma (Carcinomatosis)
  5. Osteoporosis
Show All >>

Key Therapies for Breast Neoplasms

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 630 outcomes 1763 studies in 7208 results
  2. Adjuvant Chemotherapy : 126 outcomes 423 studies in 1753 results
  3. Mastectomy (Mammectomy) : 96 outcomes 284 studies in 2088 results
  4. Heterologous Transplantation (Xenotransplantation) : 57 outcomes 110 studies in 871 results
  5. Combination Drug Therapy (Combination Chemotherapy) : 54 outcomes 134 studies in 639 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2009 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.